What is the projected market valuation of Artificial Intelligence in Bioinformatics by 2035?

The projected market valuation for Artificial Intelligence in Bioinformatics is expected to reach 38.03 USD Billion by 2035. Read More

What was the market valuation of Artificial Intelligence in Bioinformatics in 2024?

The overall market valuation for Artificial Intelligence in Bioinformatics was 8.765 USD Billion in 2024. Read More

What is the expected CAGR for the Artificial Intelligence in Bioinformatics Market from 2025 to 2035?

The expected CAGR for the Artificial Intelligence in Bioinformatics Market during the forecast period 2025 - 2035 is 14.27%. Read More

Which companies are considered key players in the Artificial Intelligence in Bioinformatics Market?

Key players in the market include IBM, Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthineers, Roche, Agilent Technologies, Boehringer Ingelheim, and GSK. Read More

What are the main applications of Artificial Intelligence in Bioinformatics and their market values?

Main applications include Drug Discovery valued at 10.5 USD Billion, Biomarker Identification at 6.5 USD Billion, and Genomics Analysis at 8.0 USD Billion by 2035. Read More

How does the deployment mode impact the market valuation of Artificial Intelligence in Bioinformatics?

The Cloud-Based deployment mode is projected to reach 23.03 USD Billion, while On-Premise is expected to reach 15.0 USD Billion by 2035. Read More

What are the data offerings in the Artificial Intelligence in Bioinformatics Market?

Data offerings include Software projected at 15.5 USD Billion and Services at 22.53 USD Billion by 2035. Read More

Who are the primary end users of Artificial Intelligence in Bioinformatics?

Primary end users include Pharmaceutical & Biotechnology Companies, expected to reach 15.0 USD Billion, and Academic & Research Institutes at 8.0 USD Billion by 2035. Read More

What is the significance of the growth in the Artificial Intelligence in Bioinformatics Market?

The growth in the market indicates a rising demand for advanced analytical tools in bioinformatics, driven by innovations from key players. Read More

How does the market for Artificial Intelligence in Bioinformatics compare across different segments?

The market shows varied growth across segments, with Drug Discovery and Cloud-Based deployment leading in projected valuations by 2035. Read More

Artificial Intelligence In Bioinformatics Market

Artificial Intelligence in Bioinformatics Market Research Report By Application (Drug Discovery & Development, Transcriptomics, Genomics Analysis, Proteomics Analysis, Metabolomics Analysis, DNA Sequencing, and Others), By Offering (Software, Services), By Deployment Mode (On-Premise, Cloud-Based), By End User (Pharmaceutical and Biotechnology Companies, Research Institutions, CDMO & CROs, Others) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East, and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

14.27%

2024 Market Size

$ 8.76 Billion

2035 Market Size

$ 38.03 Billion

Healthcare IT ● Updated May 2026 Report ID: MRFR/HCIT/20635-HCR | Pages: 144 | Author: Satyendra Maurya, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Drug Discovery
  2. 4.1.2 Biomarker Identification
  3. 4.1.3 Genomics Analysis
  4. 4.1.4 Proteomics Analysis
  5. 4.1.5 Metabolomics Analysis
2. 4.2 Healthcare, BY Deployment Mode (USD Billion)
  1. 4.2.1 On-Premise
  2. 4.2.2 Cloud-Based
3. 4.3 Healthcare, BY Data Offering (USD Billion)
  1. 4.3.1 Software
  2. 4.3.2 Services
4. 4.4 Healthcare, BY End User (USD Billion)
  1. 4.4.1 Pharmaceutical & Biotechnology Companies
  2. 4.4.2 Academic & Research Institutes
  3. 4.4.3 CDMO & CROs
  4. 4.4.4 Others
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 IBM (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Illumina (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bio-Rad Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Siemens Healthineers (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Roche (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Agilent Technologies (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Boehringer Ingelheim (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 GSK (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY DEPLOYMENT MODE
5. 6.5 US MARKET ANALYSIS BY DATA OFFERING
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 CANADA MARKET ANALYSIS BY APPLICATION
8. 6.8 CANADA MARKET ANALYSIS BY DEPLOYMENT MODE
9. 6.9 CANADA MARKET ANALYSIS BY DATA OFFERING
10. 6.10 CANADA MARKET ANALYSIS BY END USER
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
13. 6.13 GERMANY MARKET ANALYSIS BY DEPLOYMENT MODE
14. 6.14 GERMANY MARKET ANALYSIS BY DATA OFFERING
15. 6.15 GERMANY MARKET ANALYSIS BY END USER
16. 6.16 UK MARKET ANALYSIS BY APPLICATION
17. 6.17 UK MARKET ANALYSIS BY DEPLOYMENT MODE
18. 6.18 UK MARKET ANALYSIS BY DATA OFFERING
19. 6.19 UK MARKET ANALYSIS BY END USER
20. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
21. 6.21 FRANCE MARKET ANALYSIS BY DEPLOYMENT MODE
22. 6.22 FRANCE MARKET ANALYSIS BY DATA OFFERING
23. 6.23 FRANCE MARKET ANALYSIS BY END USER
24. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
25. 6.25 RUSSIA MARKET ANALYSIS BY DEPLOYMENT MODE
26. 6.26 RUSSIA MARKET ANALYSIS BY DATA OFFERING
27. 6.27 RUSSIA MARKET ANALYSIS BY END USER
28. 6.28 ITALY MARKET ANALYSIS BY APPLICATION
29. 6.29 ITALY MARKET ANALYSIS BY DEPLOYMENT MODE
30. 6.30 ITALY MARKET ANALYSIS BY DATA OFFERING
31. 6.31 ITALY MARKET ANALYSIS BY END USER
32. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
33. 6.33 SPAIN MARKET ANALYSIS BY DEPLOYMENT MODE
34. 6.34 SPAIN MARKET ANALYSIS BY DATA OFFERING
35. 6.35 SPAIN MARKET ANALYSIS BY END USER
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY DEPLOYMENT MODE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY DATA OFFERING
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY APPLICATION
42. 6.42 CHINA MARKET ANALYSIS BY DEPLOYMENT MODE
43. 6.43 CHINA MARKET ANALYSIS BY DATA OFFERING
44. 6.44 CHINA MARKET ANALYSIS BY END USER
45. 6.45 INDIA MARKET ANALYSIS BY APPLICATION
46. 6.46 INDIA MARKET ANALYSIS BY DEPLOYMENT MODE
47. 6.47 INDIA MARKET ANALYSIS BY DATA OFFERING
48. 6.48 INDIA MARKET ANALYSIS BY END USER
49. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
50. 6.50 JAPAN MARKET ANALYSIS BY DEPLOYMENT MODE
51. 6.51 JAPAN MARKET ANALYSIS BY DATA OFFERING
52. 6.52 JAPAN MARKET ANALYSIS BY END USER
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY DEPLOYMENT MODE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY DATA OFFERING
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER
57. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
58. 6.58 MALAYSIA MARKET ANALYSIS BY DEPLOYMENT MODE
59. 6.59 MALAYSIA MARKET ANALYSIS BY DATA OFFERING
60. 6.60 MALAYSIA MARKET ANALYSIS BY END USER
61. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
62. 6.62 THAILAND MARKET ANALYSIS BY DEPLOYMENT MODE
63. 6.63 THAILAND MARKET ANALYSIS BY DATA OFFERING
64. 6.64 THAILAND MARKET ANALYSIS BY END USER
65. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
66. 6.66 INDONESIA MARKET ANALYSIS BY DEPLOYMENT MODE
67. 6.67 INDONESIA MARKET ANALYSIS BY DATA OFFERING
68. 6.68 INDONESIA MARKET ANALYSIS BY END USER
69. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
70. 6.70 REST OF APAC MARKET ANALYSIS BY DEPLOYMENT MODE
71. 6.71 REST OF APAC MARKET ANALYSIS BY DATA OFFERING
72. 6.72 REST OF APAC MARKET ANALYSIS BY END USER
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
75. 6.75 BRAZIL MARKET ANALYSIS BY DEPLOYMENT MODE
76. 6.76 BRAZIL MARKET ANALYSIS BY DATA OFFERING
77. 6.77 BRAZIL MARKET ANALYSIS BY END USER
78. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
79. 6.79 MEXICO MARKET ANALYSIS BY DEPLOYMENT MODE
80. 6.80 MEXICO MARKET ANALYSIS BY DATA OFFERING
81. 6.81 MEXICO MARKET ANALYSIS BY END USER
82. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
83. 6.83 ARGENTINA MARKET ANALYSIS BY DEPLOYMENT MODE
84. 6.84 ARGENTINA MARKET ANALYSIS BY DATA OFFERING
85. 6.85 ARGENTINA MARKET ANALYSIS BY END USER
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEPLOYMENT MODE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY DATA OFFERING
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY DEPLOYMENT MODE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY DATA OFFERING
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY DEPLOYMENT MODE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY DATA OFFERING
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER
99. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
100. 6.100 REST OF MEA MARKET ANALYSIS BY DEPLOYMENT MODE
101. 6.101 REST OF MEA MARKET ANALYSIS BY DATA OFFERING
102. 6.102 REST OF MEA MARKET ANALYSIS BY END USER
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY DEPLOYMENT MODE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY DEPLOYMENT MODE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY DATA OFFERING, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY DATA OFFERING, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.2.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.3.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.3.4 BY END USER, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.4.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.4.4 BY END USER, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.5.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.5.4 BY END USER, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.6.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.6.4 BY END USER, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.7.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.7.4 BY END USER, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.8.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.8.4 BY END USER, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.9.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.9.4 BY END USER, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.10.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.10.4 BY END USER, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.11.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.11.4 BY END USER, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.12.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.12.4 BY END USER, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.13.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.13.4 BY END USER, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.14.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.14.4 BY END USER, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.15.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.15.4 BY END USER, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.16.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.16.4 BY END USER, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.17.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.17.4 BY END USER, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.18.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.18.4 BY END USER, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.19.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.19.4 BY END USER, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.20.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.20.4 BY END USER, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.21.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.21.4 BY END USER, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.22.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.22.4 BY END USER, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.23.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.23.4 BY END USER, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.24.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.24.4 BY END USER, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.25.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.25.4 BY END USER, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.26.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.26.4 BY END USER, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.27.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.27.4 BY END USER, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.28.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.28.4 BY END USER, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.29.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.29.4 BY END USER, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY DEPLOYMENT MODE, 2025-2035 (USD Billion)
  3. 7.30.3 BY DATA OFFERING, 2025-2035 (USD Billion)
  4. 7.30.4 BY END USER, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Artificial Intelligence In Bioinformatics Market Segmentation

Artificial Intelligence In Bioinformatics Market By Application (USD Billion, 2025-2035)

Drug Discovery
Biomarker Identification
Genomics Analysis
Proteomics Analysis
Metabolomics Analysis

Artificial Intelligence In Bioinformatics Market By Deployment Mode (USD Billion, 2025-2035)

On-Premise
Cloud-Based

Artificial Intelligence In Bioinformatics Market By Data Offering (USD Billion, 2025-2035)

Software
Services

Artificial Intelligence In Bioinformatics Market By End User (USD Billion, 2025-2035)

Artificial Intelligence In Bioinformatics Market & Biotechnology Companies
Academic & Research Institutes
CDMO & CROs
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035